FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:539-540 August 12, 1999 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Khamashta, M. A. Related Article by Kearon, C. PubMed Citation

To the Editor: Kearon et al. (March 25 issue)¹ tested the hypothesis that patients with a first episode of idiopathic venous thromboembolism would benefit from a course of anticoagulant therapy lasting more than three months. The authors found that patients who continued taking oral anticoagulants after receiving an initial course of treatment lasting three months had few recurrences or none, whereas those who stopped warfarin after three months had a high rate of recurrence, mainly in the first six months after the discontinuation of treatment. Unfortunately, the study did not determine whether anticoagulation reduces the risk of recurrence or simply . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.